Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

China SXT Pharmaceuticals (SXTC) Equity Ratio: 2019-2025

  • China SXT Pharmaceuticals' Equity Ratio rose 58.29% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year increase of 58.29%. This contributed to the annual value of 0.71 for FY2025, which is 18.32% up from last year.
  • China SXT Pharmaceuticals' Equity Ratio amounted to 0.77 in Q3 2025, which was up 7.73% from 0.71 recorded in Q1 2025.
  • China SXT Pharmaceuticals' Equity Ratio's 5-year high stood at 0.77 during Q3 2025, with a 5-year trough of 0.35 in Q3 2023.
  • For the 3-year period, China SXT Pharmaceuticals' Equity Ratio averaged around 0.57, with its median value being 0.55 (2023).
  • As far as peak fluctuations go, China SXT Pharmaceuticals' Equity Ratio plummeted by 48.16% in 2023, and later spiked by 58.29% in 2025.
  • Quarterly analysis of 5 years shows China SXT Pharmaceuticals' Equity Ratio stood at 0.61 in 2021, then rose by 10.34% to 0.67 in 2022, then plummeted by 48.16% to 0.35 in 2023, then soared by 39.39% to 0.49 in 2024, then soared by 58.29% to 0.77 in 2025.
  • Its Equity Ratio was 0.77 in Q3 2025, compared to 0.71 in Q1 2025 and 0.49 in Q3 2024.